Department of Medicine, Prince Henry's Institute of Medical Research, Monash University, Clayton, Victoria 3168, Australia.
Mol Cell Endocrinol. 2012 Mar 24;350(2):196-205. doi: 10.1016/j.mce.2011.07.001. Epub 2011 Jul 18.
The mineralocortoid receptor (MR) regulates salt homeostasis in the kidneys and plays a range of other roles in the heart, vasculature, brain and adipose tissue. It interacts with both mineralocorticoids and glucocorticoids to mediate transcription of target genes. The ability of the MR to exert tissue- and ligand-specific effects relies on its interactions with a range of binding partners, including the chaperone proteins, coregulators, other transcription factors, DNA and modifying proteins. Interactions within the domains of the MR also modulate the overall transcriptional complex. This review will discuss the current understanding of interactions involving the MR and highlight their relevance to ligand- or tissue-specificity as well as their suitability as therapeutic targets.
矿物质皮质激素受体(MR)调节肾脏中的盐稳态,并在心脏、血管、大脑和脂肪组织中发挥多种其他作用。它与矿物质皮质激素和糖皮质激素相互作用,介导靶基因的转录。MR 发挥组织和配体特异性作用的能力依赖于其与一系列结合伴侣的相互作用,包括伴侣蛋白、共调节剂、其他转录因子、DNA 和修饰蛋白。MR 结构域内的相互作用也调节整体转录复合物。这篇综述将讨论涉及 MR 的相互作用的现有认识,并强调它们与配体或组织特异性的相关性,以及它们作为治疗靶点的适用性。